Borosil Scientific Ltd

Borosil Scientific Limited will hold a board meeting on Wednesday, October 28, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for equity shares of the company for designated persons and their immediate relatives will remain closed until 48 hours after the results are declared.

Borosil Scientific Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited, for the quarter ended September 30, 2026, confirming that all securities of the company are in dematerialized form and no Demat/Ramat requests were received from any depositories between July 1, 2026, and September 30, 2026, as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018; the certificate was provided by MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited.

Borosil Scientific Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's equity shares will be closed for designated persons and their immediate relatives from October 01, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, with the date of the board meeting to consider and approve the results to be announced separately.

Borosil Scientific Limited announced September 22, 2026, that its board approved a proposal to expand production capacity for glassware products by establishing an additional manufacturing facility in Bharuch, Gujarat, increasing capacity from approximately 15 lakh units per annum to approximately 108 lakh units per annum, with commercial production expected to begin by March 2027, requiring an estimated capital expenditure of Rs 60 crore to be financed through internal accruals and/or borrowings, in response to growing demand from Borosil Limited.

Borosil Scientific Limited announced the allotment of 4,475 equity shares following the exercise of vested options under its Borosil Scientific Limited – Employee Stock Option Scheme (BSL-ESOS), increasing the company’s issued and paid-up equity share capital to Rs 8,89,51,525 divided into 8,89,51,525 equity shares. The allotment was approved on August 13, 2026, and received in-principle approval from both the National Stock Exchange of India Limited and BSE Limited on November 11, 2024.

Borosil Scientific Ltd share price declined by 3.61% to Rs 152.2 after the company's net profit plunged by 84% to Rs 4.36 crore, while revenue from operations nosedived 25.44% to Rs 106.75 crore in Q2FY26 over Q1FY26. The market capitalization of Glass - Industrial industry group stocks on BSE stood at Rs 9250.1 crore, slipping 9.64%. It has eased by 4.16% over last one week and advanced by 8.75% in last one month while the market capitalization of Borosil Scientific Ltd has softened by 1.84% and 30.09% in the same period respectively. Profit before tax (PBT) of Borosil Scientific Ltd stood at Rs 5.98 crore in Q2 FY26, crashing by 246.57% year-on-year, and tanking 79.49% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 195.41% YoY and plunging by 80.73% sequentially. Total expenses dropped by 10.91% to Rs 103.18 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 41.01 crore, slightly declining by 7.78% YoY, while employee benefits expense was at Rs 21.98 crore, soaring 22.52% YoY. For the TTM ended FY26, revenue from operations rose 10.74% to Rs 438.49 crore, while net profit expanded by 13.80% to Rs 26.72 crore, compared to previous TTM. EBITDA soared by 4369% to Rs 44.77 crore, and PBT soared 28.02% to Rs 40.39 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 120.03 crore in FY26, as against Rs 30.0 crore in FY25. Borosil Scientific Ltd slipped 3.72% in last one year, performing in line with the benchmark BSE Sensex which has eased by 3.81% during the same period.

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 3 August 2026.

Net profit of Borosil Scientific rose 213.84% to Rs 27.21 crore in the quarter ended March 2026 as against Rs 8.67 crore during the previous quarter ended March 2025. Sales rose 10.57% to Rs 143.17 crore in the quarter ended March 2026 as against Rs 129.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 29.14% to Rs 34.61 crore in the year ended March 2026 as against Rs 26.80 crore during the previous year ended March 2025. Sales rose 6.58% to Rs 467.34 crore in the year ended March 2026 as against Rs 438.49 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales143.17129.48 11 467.34438.49 7 OPM %22.4312.80 -13.3111.99 - PBDT33.9118.72 81 70.6158.87 20 PBT29.1514.02 108 51.3740.39 27 NP27.218.67 214 34.6126.80 29 Powered by Capital Market - Live

The board of Borosil Scientific at its meeting held on 20 May 2026 has decided to seek the approval of the shareholders by way of an enabling resolution at the ensuing Annual General Meeting, authorising the Board to raise funds, as and when required, up to an amount of Rs. 250 crore, using such modes as the Board may determine including by way of qualified institutional placement, further public officer, FCCBs or any other method or a combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals, as may be required.

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 20 May 2026.